Literature DB >> 8294453

Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.

K Paananen1, P T Kovanen.   

Abstract

Contact between low density lipoproteins (LDL) and exocytosed mast cell granules, the "granule remnants," leads to binding of LDL to the granule remnants via ionic interactions between the apolipoprotein B-100 (apoB-100) component of LDL and the heparin proteoglycan component of the granule remnants. Upon incubation at 37 degrees C, the heparin proteoglycan-bound apoB-100 is progressively proteolyzed by remnant chymase and carboxypeptidase A, which are also bound to the heparin proteoglycans. Thereupon, the LDL particles fuse, and their binding to the granule remnants strengthens, as defined by the decreased ability of NaCl to release LDL from the remnants. We now have examined separately the effects of proteolysis and fusion on LDL binding. Proteolysis without fusion was induced by lowering the incubation temperature to 15 degrees C, and proteolysis-independent fusion was induced by treating granule remnant-bound LDL with sphingomyelinase in the presence of protease inhibitors. It was found that degradation of the heparin proteoglycan-bound apoB-100, even without accompanying particle fusion, increased the strength of LDL binding to the granule remnants, suggesting exposure of buried heparin binding regions of apoB-100. When such proteolyzed LDL particles were allowed to fuse, the strength of their binding to the granule remnants increased still further, probably because of an increase in the number of apoB-100 fragments in the enlarged particles. Proteolysis-independent fusion, induced by sphingomyelinase treatment of granule remnant-bound LDL, also increased the strength of binding. The results show that proteolytic degradation and fusion, the two modifications of granule remnant-bound LDL subsequent to action by chymase and carboxypeptidase A of the granule remnants, represent two separate mechanisms by which LDL particles become tightly bound to the heparin proteoglycans of exocytosed mast cell granules. Since the formation of an atheroma, the hallmark of atherosclerosis, is characterized by accumulation in the proteoglycan matrix of the arterial intima of extracellular lipid droplets resembling the fused LDL particles on the granule remnant surfaces, the modifications of LDL described in this study may provide a clue to the actual processes by which the lipid droplets are anchored to the arterial intima.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Authors:  J Borén; K Olin; I Lee; A Chait; T N Wight; T L Innerarity
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

2.  Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.

Authors:  Riia Plihtari; Eva Hurt-Camejo; Katariina Oörni; Petri T Kovanen
Journal:  J Lipid Res       Date:  2010-02-01       Impact factor: 5.922

3.  Direct observation of lipoprotein cholesterol ester degradation in lysosomes.

Authors:  S Lusa; K Tanhuanpää; T Ezra; P Somerharju
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.

Authors:  Naotaka Shiota; Eiichi Kakizoe; Keiko Shimoura; Tetsuya Tanaka; Hideki Okunishi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.

Authors:  Mia Sneck; Su Duy Nguyen; Tero Pihlajamaa; Gebrenegus Yohannes; Marja-Liisa Riekkola; Ross Milne; Petri T Kovanen; Katariina Oörni
Journal:  J Lipid Res       Date:  2012-06-20       Impact factor: 5.922

6.  Cathepsin G activity lowers plasma LDL and reduces atherosclerosis.

Authors:  Jing Wang; Sara Sjöberg; Ting-Ting Tang; Katariina Oörni; Wenxue Wu; Conglin Liu; Blandine Secco; Viviane Tia; Galina K Sukhova; Cleverson Fernandes; Adam Lesner; Petri T Kovanen; Peter Libby; Xiang Cheng; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-08-01

7.  An immune response network associated with blood lipid levels.

Authors:  Michael Inouye; Kaisa Silander; Eija Hamalainen; Veikko Salomaa; Kennet Harald; Pekka Jousilahti; Satu Männistö; Johan G Eriksson; Janna Saarela; Samuli Ripatti; Markus Perola; Gert-Jan B van Ommen; Marja-Riitta Taskinen; Aarno Palotie; Emmanouil T Dermitzakis; Leena Peltonen
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

Review 8.  Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.

Authors:  Lisa R Tannock; Victoria L King
Journal:  Rev Endocr Metab Disord       Date:  2008-06-27       Impact factor: 6.514

9.  Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.

Authors:  N Shiota; A Fukamizu; H Okunishi; S Takai; K Murakami; M Miyazaki
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

10.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.